Equifax Total Liab vs Cash And Equivalents Analysis
EFX Stock | USD 231.39 1.80 0.78% |
Equifax financial indicator trend analysis is much more than just examining Equifax latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Equifax is a good investment. Please check the relationship between Equifax Total Liab and its Cash And Equivalents accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equifax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy Equifax Stock please use our How to Invest in Equifax guide.
Total Liab vs Cash And Equivalents
Total Liab vs Cash And Equivalents Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Equifax Total Liab account and Cash And Equivalents. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Equifax's Total Liab and Cash And Equivalents is 0.44. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Cash And Equivalents in the same time period over historical financial statements of Equifax, assuming nothing else is changed. The correlation between historical values of Equifax's Total Liab and Cash And Equivalents is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Equifax are associated (or correlated) with its Cash And Equivalents. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Equivalents has no effect on the direction of Total Liab i.e., Equifax's Total Liab and Cash And Equivalents go up and down completely randomly.
Correlation Coefficient | 0.44 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Cash And Equivalents
Most indicators from Equifax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Equifax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equifax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy Equifax Stock please use our How to Invest in Equifax guide.At this time, Equifax's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 33.69 in 2024, whereas Selling General Administrative is likely to drop slightly above 731.1 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.9B | 2.9B | 2.3B | 1.2B | Total Revenue | 4.9B | 5.1B | 5.3B | 5.5B |
Equifax fundamental ratios Correlations
Click cells to compare fundamentals
Equifax Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Equifax fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.9B | 9.6B | 11.0B | 11.5B | 12.3B | 12.9B | |
Short Long Term Debt Total | 3.4B | 4.4B | 5.3B | 5.8B | 5.7B | 6.0B | |
Other Current Liab | 1.1B | 1.1B | 1.1B | 664.3M | 748.5M | 785.9M | |
Total Current Liabilities | 1.4B | 2.5B | 2.3B | 2.0B | 2.0B | 2.1B | |
Total Stockholder Equity | 2.6B | 3.2B | 3.6B | 4.0B | 4.5B | 4.8B | |
Property Plant And Equipment Net | 947.6M | 1.1B | 1.3B | 1.6B | 1.8B | 1.9B | |
Net Debt | 3.0B | 2.7B | 5.1B | 5.5B | 5.5B | 5.8B | |
Retained Earnings | 4.1B | 4.2B | 4.8B | 5.3B | 5.6B | 5.9B | |
Cash | 401.3M | 1.7B | 224.7M | 285.2M | 216.8M | 162.5M | |
Non Current Assets Total | 6.7B | 7.1B | 9.9B | 10.2B | 10.9B | 11.5B | |
Non Currrent Assets Other | 304.2M | 405.6M | 353.1M | (241.6M) | (1.6B) | (1.5B) | |
Cash And Short Term Investments | 401.3M | 1.7B | 224.7M | 285.2M | 216.8M | 162.5M | |
Net Receivables | 532.1M | 630.6M | 727.6M | 857.7M | 917.2M | 963.1M | |
Liabilities And Stockholders Equity | 7.9B | 9.6B | 11.0B | 11.5B | 12.3B | 12.9B | |
Non Current Liabilities Total | 3.9B | 3.9B | 5.1B | 5.6B | 5.6B | 5.9B | |
Other Current Assets | 187.9M | 59M | 60.2M | 93.3M | 231.3M | 242.9M | |
Other Stockholder Equity | (1.2B) | (1.1B) | (1.1B) | (1.1B) | (879.9M) | (835.9M) | |
Total Liab | 5.3B | 6.4B | 7.4B | 7.6B | 7.6B | 8.0B | |
Total Current Assets | 1.2B | 2.5B | 1.1B | 1.4B | 1.4B | 1.4B | |
Short Term Debt | 3.1M | 1.1B | 824.8M | 967.2M | 963.4M | 1.0B | |
Intangible Assets | 1.1B | 1.1B | 2.0B | 1.9B | 2.0B | 2.1B | |
Accounts Payable | 148.3M | 159.1M | 211.6M | 250.8M | 197.6M | 207.5M | |
Property Plant And Equipment Gross | 947.6M | 1.1B | 2.3B | 2.7B | 3.1B | 3.2B | |
Accumulated Other Comprehensive Income | (631.6M) | (171.4M) | (295.4M) | (473.7M) | (431.2M) | (452.8M) | |
Other Liab | 467.3M | 641.1M | 678.3M | 663.9M | 763.5M | 801.7M | |
Other Assets | 304.2M | 153M | 5.9B | 293.2M | 337.2M | 467.4M | |
Long Term Debt | 3.4B | 3.3B | 4.5B | 4.8B | 4.7B | 5.0B | |
Good Will | 4.3B | 4.5B | 6.3B | 6.4B | 6.8B | 7.2B | |
Treasury Stock | (2.6B) | (2.5B) | (2.6B) | (2.7B) | (2.4B) | (2.5B) | |
Property Plant Equipment | 947.6M | 1.1B | 1.3B | 1.6B | 1.8B | 1.9B | |
Inventory | 88.1M | 104.1M | 108.4M | 134.3M | 1.0 | 0.95 | |
Current Deferred Revenue | 104M | 108.3M | 121.3M | 132.9M | 118.5M | 82.9M | |
Net Tangible Assets | (2.9B) | (2.4B) | (4.7B) | (4.3B) | (3.9B) | (3.7B) | |
Noncontrolling Interest In Consolidated Entity | 47.9M | 44.3M | 41.9M | 16.8M | 19.3M | 18.4M | |
Retained Earnings Total Equity | 4.1B | 4.2B | 4.8B | 5.3B | 6.0B | 4.3B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Equifax offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Equifax's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Equifax Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Equifax Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equifax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy Equifax Stock please use our How to Invest in Equifax guide.Note that the Equifax information on this page should be used as a complementary analysis to other Equifax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Equifax Stock analysis
When running Equifax's price analysis, check to measure Equifax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equifax is operating at the current time. Most of Equifax's value examination focuses on studying past and present price action to predict the probability of Equifax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equifax's price. Additionally, you may evaluate how the addition of Equifax to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Transaction History View history of all your transactions and understand their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Equifax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equifax. If investors know Equifax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equifax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.099 | Dividend Share 1.56 | Earnings Share 4.49 | Revenue Per Share 43.473 | Quarterly Revenue Growth 0.067 |
The market value of Equifax is measured differently than its book value, which is the value of Equifax that is recorded on the company's balance sheet. Investors also form their own opinion of Equifax's value that differs from its market value or its book value, called intrinsic value, which is Equifax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equifax's market value can be influenced by many factors that don't directly affect Equifax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equifax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equifax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equifax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.